Modern Management of Advanced Pancreatic Cancer: Expert Answers to Frequently Asked Questions
Source: Modern Management of Advanced Pancreatic Cancer: Expert Guidance on Clinical Challenges

Module

Expert answers to frequently asked questions about modern clinical management of pancreatic cancer, including diagnosis, screening, selecting chemotherapeutic agents, switching treatment, radiation, and surgery.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply current guidelines and clinical findings to select individualized therapies for patients with newly diagnosed advanced pancreatic cancer
  • Plan treatment strategies for patients with advanced pancreatic cancer after progression on first-line systemic therapy based on available data and treatment guidelines
  • Manage disease- and treatment-related symptoms for patients with advanced pancreatic cancer

Topics covered include:

  • Chemotherapy
  • Radiation Therapy
  • Diagnosing and Screening
 

Program Directors

  • Tanios Bekaii-Saab
    MD, FACP
    Andrew H. Ko
    MD

Faculty

  • Release Date:
    September 07, 2017

Information on this Educational Activity

Program Directors

Tanios Bekaii-Saab, MD, FACP

Professor
Mayo Clinic College of Medicine and Science
Co-Leader, GI Cancer Program
Mayo Clinic Cancer Center
Senior Associate Consultant
Mayo Clinic Arizona
Phoenix, Arizona

Tanios Bekaii-Saab, MD, FACP, has disclosed that he has received consulting fees from Celgene, Genentech, and Merrimack.

 

Andrew H. Ko, MD

Professor
Division of Hematology/Oncology
Department of Medicine
University of California, San Francisco
San Francisco, California

Andrew H. Ko, MD, has disclosed that he has received consulting fees from New β Innovations and Seattle Genetics and funds for research support from Aduro Biotech, Celgene, Merrimack, and Prism Bio.

 

Faculty

 

Staff

Terrence Fagan, 


Associate Managing Editor

Terrence Fagan has no real or apparent conflicts of interest to report.
 

Krista Marcello, 


Managing Editor

Krista Marcello has no real or apparent conflicts of interest to report.
 

Kevin Obholz, PhD


Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.
 

Jayoo Gokhale, 


Editorial Contributor

Jayoo Gokhale, PhD, has no real or apparent conflicts of interest to report.